RxSight (RXST) Interest & Investment Income (2020 - 2026)
RxSight's (RXST) quarterly Interest & Investment Income came in at $2.0 million in Q1 2026, down 22.09% YoY from $2.5 million in Q1 2025, and down 10.98% on a QoQ basis from $2.2 million in Q4 2025.
RxSight (RXST) Interest & Investment Income (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Interest & Investment Income data on file, last reported at $2.0 million in Q1 2026.
- Quarterly Interest & Investment Income fell 22.09% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (down 15.56% YoY) and the FY2025 annual result came in at $9.3 million, down 1.5% from the prior year.
- Interest & Investment Income eased to $2.0 million in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.9 million in Q3 2024 to a low of $46000.0 in Q1 2022.
- A 5-year average of $1.7 million and a median of $1.8 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 8260.0% — and 2026, when it slipped 22.09%.
- Tracing RXST's Interest & Investment Income over 5 years: stood at $836000.0 in 2022, then surged by 98.68% to $1.7 million in 2023, then soared by 62.97% to $2.7 million in 2024, then slipped by 18.91% to $2.2 million in 2025, then slipped by 10.98% to $2.0 million in 2026.
- The last three Interest & Investment Income figures came in at $2.0 million (Q1 2026), $2.2 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | - |
| 10 | RxSight | 247.91 Mn | -156.34 Mn | - | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Mn |
| Mar 31, 2026 | 1.95 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 2.28 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.66 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 836,000.00 |
| Sep 30, 2022 | 439,000.00 |
| Jun 30, 2022 | 196,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 11,000.00 |